Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000861072 | SCV001001287 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000861072 | SCV005274646 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000861072 | SCV001808896 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000861072 | SCV001970657 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003975367 | SCV004798322 | benign | TAF1-related disorder | 2019-07-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |